CELLiST™ product line offers a high-productivity solution for your HEK293-based viral vector vaccine manufacturing. To overcome the challenges of enhancing both cell growth and viral productivity in HEK293-based vaccine production, CELLiST™ HEK293 Vaccine Media is specifically formulated for optimal process productivity. CELLiST™ HEK293 Vaccine Media is completely chemically-defined and free from animal-origin components. In addition, a HEK293 Vaccine Supplement was developed to boost viral production when combined with any other commercially available
vaccine production media. This specially formulated supplement can dramatically improve productivity of any existing process, used in combination with any HEK293 media.
CELLiST™ HEK293 Vaccine Media and Supplement integrate Ajinomoto Group’s expertise in AminoScience, accumulated over 70 years of extensive research and development, ensuring refined and expertly formulated medium for optimal viral vaccine production.